233,185 Shares in Kenvue Inc. (NYSE:KVUE) Bought by Caisse Des Depots ET Consignations

Caisse Des Depots ET Consignations bought a new position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 233,185 shares of the company's stock, valued at approximately $4,978,000.

Other hedge funds have also recently bought and sold shares of the company. Grove Bank & Trust increased its position in shares of Kenvue by 438.4% in the fourth quarter. Grove Bank & Trust now owns 1,163 shares of the company's stock worth $25,000 after acquiring an additional 947 shares in the last quarter. Geneos Wealth Management Inc. acquired a new stake in Kenvue in the 4th quarter valued at $29,000. SRS Capital Advisors Inc. raised its position in Kenvue by 67.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock valued at $30,000 after purchasing an additional 571 shares during the period. Fortitude Family Office LLC lifted its stake in shares of Kenvue by 106.6% during the fourth quarter. Fortitude Family Office LLC now owns 1,506 shares of the company's stock worth $32,000 after purchasing an additional 777 shares in the last quarter. Finally, Versant Capital Management Inc boosted its position in shares of Kenvue by 300.8% in the fourth quarter. Versant Capital Management Inc now owns 1,920 shares of the company's stock worth $41,000 after buying an additional 1,441 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently commented on the company. Deutsche Bank Aktiengesellschaft lowered Kenvue from a "buy" rating to a "hold" rating and reduced their price target for the stock from $25.00 to $24.00 in a research report on Thursday, December 12th. Evercore ISI started coverage on shares of Kenvue in a research note on Monday, March 24th. They issued an "in-line" rating and a $25.00 target price for the company. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $24.00 price target on shares of Kenvue in a research note on Monday, February 3rd. UBS Group decreased their price objective on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating for the company in a research report on Friday, February 7th. Finally, Barclays lifted their target price on Kenvue from $21.00 to $23.00 and gave the stock an "equal weight" rating in a research report on Thursday. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $24.00.

Remove Ads

Kenvue Stock Performance

Shares of NYSE KVUE traded up $0.05 during midday trading on Monday, hitting $23.75. The company's stock had a trading volume of 5,879,730 shares, compared to its average volume of 16,703,482. The firm has a market cap of $45.38 billion, a P/E ratio of 44.76, a P/E/G ratio of 2.62 and a beta of 1.25. The firm's fifty day moving average price is $22.32 and its 200-day moving average price is $22.45. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $24.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, meeting the consensus estimate of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, sell-side analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th were given a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a dividend yield of 3.45%. The ex-dividend date of this dividend was Wednesday, February 12th. Kenvue's dividend payout ratio (DPR) is presently 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.